[HTML][HTML] Pharmacological induction of RAS-GTP confers RAF inhibitor sensitivity in KRAS mutant tumors
I Yen, F Shanahan, M Merchant, C Orr, T Hunsaker… - Cancer Cell, 2018 - cell.com
Targeting KRAS mutant tumors through inhibition of individual downstream pathways has
had limited clinical success. Here we report that RAF inhibitors exhibit little efficacy in KRAS …
had limited clinical success. Here we report that RAF inhibitors exhibit little efficacy in KRAS …
[PDF][PDF] Pharmacological Induction of RAS-GTP Confers RAF Inhibitor Sensitivity in KRAS Mutant Tumors
I Yen, F Shanahan, M Merchant, C Orr, T Hunsaker… - Cancer Cell, 2018 - academia.edu
Targeting KRAS mutant tumors through inhibition of individual downstream pathways has
had limited clinical success. Here we report that RAF inhibitors exhibit little efficacy in KRAS …
had limited clinical success. Here we report that RAF inhibitors exhibit little efficacy in KRAS …
Pharmacological Induction of RAS-GTP Confers RAF Inhibitor Sensitivity in KRAS Mutant Tumors.
I Yen, F Shanahan, M Merchant, C Orr, T Hunsaker… - Cancer Cell, 2018 - europepmc.org
Targeting KRAS mutant tumors through inhibition of individual downstream pathways has
had limited clinical success. Here we report that RAF inhibitors exhibit little efficacy in KRAS …
had limited clinical success. Here we report that RAF inhibitors exhibit little efficacy in KRAS …
Pharmacological Induction of RAS-GTP Confers RAF Inhibitor Sensitivity in KRAS Mutant Tumors
I Yen, F Shanahan, M Merchant, C Orr… - Cancer …, 2018 - pubmed.ncbi.nlm.nih.gov
Targeting KRAS mutant tumors through inhibition of individual downstream pathways has
had limited clinical success. Here we report that RAF inhibitors exhibit little efficacy in KRAS …
had limited clinical success. Here we report that RAF inhibitors exhibit little efficacy in KRAS …
[HTML][HTML] Pharmacological Induction of RAS-GTP Confers RAF Inhibitor Sensitivity in KRAS Mutant Tumors
I Yen, F Shanahan, M Merchant, C Orr, T Hunsaker… - Cancer Cell, 2018 - Elsevier
Targeting KRAS mutant tumors through inhibition of individual downstream pathways has
had limited clinical success. Here we report that RAF inhibitors exhibit little efficacy in KRAS …
had limited clinical success. Here we report that RAF inhibitors exhibit little efficacy in KRAS …
[PDF][PDF] Pharmacological Induction of RAS-GTP Confers RAF Inhibitor Sensitivity in KRAS Mutant Tumors
I Yen, F Shanahan, M Merchant, C Orr, T Hunsaker… - Cancer Cell, 2018 - academia.edu
Targeting KRAS mutant tumors through inhibition of individual downstream pathways has
had limited clinical success. Here we report that RAF inhibitors exhibit little efficacy in KRAS …
had limited clinical success. Here we report that RAF inhibitors exhibit little efficacy in KRAS …